Connect with us

Uncategorized

Medipharm Labs Forms Strategic Partnership To Execute On Clinical Trials Leveraging Proprietary Cannabis-Derived Formulations

Earlier this month, we highlighted MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) as an opportunity that is in the middle of a major transformation and is one that we are excited about. The Canadian cannabis company is considered to be a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products. […]

The post Medipharm Labs Forms Strategic Partnership To Execute On Clinical Trials Leveraging Proprietary Cannabis-Derived Formulations appeared first on Technical420.

Republished by Plato

Published

on

Earlier this month, we highlighted MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) as an opportunity that is in the middle of a major transformation and is one that we are excited about. The Canadian cannabis company is considered to be a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products.

MediPharm has recently become highly focused on the biotech side of the cannabis industry and this is an opportunity that we are excited about. The company recently announced plans to conduct a clinical trial to evaluate the effectiveness of the company’s proprietary cannabis-derived formulations and medical products. The initiative is also focused on the expansion of the intellectual property (IP) that is owned by the business and we are favorable on how it further differentiates the business.

The clinical trial is focused on the treatment of end-stage renal disease or Chronic Kidney Disease (CKD). The size of the total addressable market for this indication is significant and consider this to be an important aspect of the story. According to the National Kidney Foundation, 1 out of 10 people in the world suffer from kidney disease and this represents a major opportunity for MediPharm. According to the foundation, CKD causes more deaths than breast cancer or prostate cancer. CKD is the 9th leading cause of death in the US affects approx. 37 million people.

MediPharm is considered to be a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products. We consider the development to major milestone for the business and will monitor how the management team is able to execute on the opportunity.

Forms Strategic Relationship to Execute on Clinical Trials

Since we started to follow MediPharm, we have been impressed with the types of companies that it has formed relationships with. As it relates to the clinical trial, MediPharm decided to partner with Canadian firm, OTT Healthcare Inc. (OTT) and signed a Master Clinical Studies agreement.

As the expert principal investigator, OTT will study the pharmacokinetic (dosing) and safety profile of cannabinoid formulations for the CKD patient population and assess pain. OTT will determine Quality of Life (QOL) scores of patients who receive MediPharm Labs’ proprietary product formulations. In regard to the patient base, optimizing QOL is of high priority for MediPharm and we are closely following the progression of the study.

After the initial patient base receives MediPharm’s proprietary cannabis formulations, OTT will use the data to support follow-on randomized double-blind clinical trials to establish the safety and efficacy of these products. Any results from the study as well as the IP and inventions will be owned by MediPharm and we are favorable on the potential that is associated with the study.

MediPharm Labs and OTT Healthcare will co-develop the study drugs that will be evaluated and name each principal investigator physician. The principal investigators will be accountable for the direction of each study and will be chosen because of their leadership in the field of Nephrology.

We believe that clinical trials of this nature position the cannabis industry for the development of safe, effective pharmaceutical-grade products and we are favorable on the direction that the management team is taking the business.

A Growth Story that is Flying Under the Radar

During the last few years, MediPharm has established itself as a leading producer of pharmaceutical quality cannabis active pharmaceutical ingredients (API) and formulations. The company is well positioned to support clinical trials that are focused on nephrology and provide novel formulations.

The start of the clinical trial represents a new chapter for MediPharm and we are bullish on the growth prospects that are associated with it. The clinical trial shows how much the business has evolved and how it is growing as a research-driven pharmaceutical focused company that has global aspirations.

In late 2019, MediPharm was granted a cannabis research license from Health Canada to conduct controlled human administration trials of dried cannabis, cannabis extracts and concentrates, distillates, oil, edibles, topicals and terpenes. We are impressed with how the story has advanced since then and believe that the opportunity is flying under the radar.

Pursuant to an agreement between StoneBridge Partners LLC and Medipharm Labs we have been hired for a period of 180 days beginning August 18, 2020 and ending March 18, 2020 to publicly disseminate information about (LABS) including on the Website and other media including Facebook and Twitter. We are being paid $6,000 per month (LABS) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero (0) shares of (LABS), which we purchased in the open market. We plan to sell the “ZERO” shares of (LABS) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LABS) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Share Share - Facebook Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Source: https://technical420.com/cannabis-article/medipharm-labs-forms-strategic-partnership-to-execute-on-clinical-trials-leveraging-proprietary-cannabis-derived-formulations/

Uncategorized

Namaste Technologies Adds CannMart Labs as Wholly Owned Subsidiary and Provides Corporate Update Including Announcement of Virtual Town Hall

Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF ), a leading platform for cannabis products, accessories, and education, is pleased to provide shareholders a corporate update on its recent activities: Cyber Weekend Highlights: Average order value increased 42% compared to 2019 to $192 Online traffic increased 50% over 2019 cyber weekend 40% more giveaway […]

The post Namaste Technologies Adds CannMart Labs as Wholly Owned Subsidiary and Provides Corporate Update Including Announcement of Virtual Town Hall appeared first on Technical420.

Republished by Plato

Published

on

Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF ), a leading platform for cannabis products, accessories, and education, is pleased to provide shareholders a corporate update on its recent activities:

Cyber Weekend Highlights:

  • Average order value increased 42% compared to 2019 to $192
  • Online traffic increased 50% over 2019 cyber weekend
  • 40% more giveaway entries than expected. These entries generated email newsletter sign ups, increased social media visits and interactions
  • Best sales in Dried Flower: Sage n Sour and Sensi Star, both under the CannMart brand
  • Best sales in Cartridges : Disposable Cart Bundle and Pink Kush 0.5g Cart, both under the CannMart licensed Phyto Extractions brand
  • Best sales in Edibles : Strawberry Lemonade 1:1 Sour Gummies and Watermelon Hybrid Sour Gummies, both under the Wana brand supplied by Indiva
  • Best sales in Infused Oils : Treasure Island CBD Tincture under the CannMart brand and CBD Soft Gels under the brand and supplied by Indiva

“We are pleased by activity this past cyber weekend to see our own CannMart and licensed brands shine alongside our valued partner brands which is a clear validation by consumers that our strategy is working,” said Meni Morim , CEO of Namaste. “Our average order value increased by 42% compared to 2019, demonstrating that our investment into our e-commerce platform is driving solid results. We are clearly focused on the execution of our strategy to position Namaste as a leading cannabis company and look forward to building on this positive momentum as we head into the upcoming holiday season.”

Save the Date – Namaste Virtual Town Hall:

  • We have been actively listening to our shareholders and would like to announce a virtual town hall so they can hear an in depth presentation on the future direction of the Company
  • Wednesday, December 16 th
  • 12:00 p.m. EST
  • Presentation by Meni Morim followed by Q&A
  • All Shareholders are invited to submit their questions by December 14 th to: ir@namastetechnologies.com . Our CEO, Meni Morim , will answer submitted investors questions during the town hall event.

Completion of Acquisition of 49% Interest in CannMart Labs:

Namaste has completed the acquisition of the remaining 49% interest in CannMart Labs Inc. (” CannMart Labs “), an applicant for a processing licence under the Cannabis Act ( Canada ) for cannabis extraction activities, pursuant to the previously announced share purchase agreement (the ” Share Purchase Agreement “) entered into among Namaste and MKD Holdings Inc. and JLLS Holdings Inc. (together, the ” Vendors “).

Execution of the Share Purchase Agreement was first announced by the Company on November 18, 2020 , confirming a purchase price of $4,034,000 (the “Purchase Price “), and earn-out payments in the form of Namaste common shares, on a sliding scale, upon the achievement of pre-determined revenue targets (the ” Earn-Out Payments “) payable over 9 fiscal quarters at a maximum of approximately $1.94M per Earn-Out Payment, payable in Namaste common shares or, at Namaste’s option, in cash with a 5% discount. A first tranche of the Purchase Price of $1,608,500 has been paid to the Vendors by way of issuance of 7,123,560 Namaste common shares, issued at a deemed price of $0.2258 , being the 7-day VWAP up to and including December 1, 2020 .

Appointment of Vice President, Investor Relations:

Namaste is pleased to announce the appointment of Edward Miller as Vice President, Investor Relations effective November 16 , 2020.  Mr. Miller brings more than 20 years experience as a seasoned investor relations professional in the pharmaceutical and cannabis industry.  Mr. Miller has built several award-winning programs and this appointment affirms the Company’s clear commitment to increasing and improving its dialogue with shareholders going forward.

Subject to Exchange approval, Namaste has granted Mr. Miller options to acquire 170,000 common shares in the capital of the Company at a price of CAD$0.23per share that vest quarterly over 3 years and have a four-year term.

Announcement of Whistle Blowing System:

The Company is committed to integrity and honesty. Affirming said commitment, Namaste has launched a Whistle-blower Program that allows employees to anonymously and confidentially report cases of workplace misconduct.  The program is supported by ClearView Connects™, a Canadian-based reporting solution provided by an independent, third-party supplier.  Employees can safely and anonymously submit reports or questions through ClearView’s secure website, toll-free telephone hotline or post office box.  ClearView Connects™ is easy to use and available 24/7.

About Namaste Technologies Inc.

Headquartered in Toronto, Canada , Namaste Technologies is a leading online platform for cannabis products, accessories, and responsible education. The Company’s ‘everything cannabis store’, CannMart.com, provides medical customers with a diverse selection of hand-picked products from a multitude of federally-licensed cultivators, all on one convenient site. The Company also distributes licensed and in-house branded cannabis and cannabis derived products to recreational consumers in Canada through a number of provincial government control boards and retailing bodies and facilitates licensed cannabis retailer sales online in Saskatchewan . Namaste’s global technology and continuous innovation address local needs in a burgeoning cannabis industry requiring smart solutions.

Information on the Company and its many products can be accessed through the links below:
NamasteTechnologies.com
NamasteMD.com
Cannmart.com

FORWARD-LOOKING INFORMATION – This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as “may”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen. The forward-looking information contained herein, including, without limitation, statements related to the future success of Namaste’s business strategy, is made as of the date of this press release and is based on assumptions management believed to be reasonable at the time, including, without limitation, Namaste’s standing in the online marketplace for cannabis products, Namaste’s beliefs regarding the expected demand for cannabis products and the expected growth of that market, results of operations, operational matters, historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: regulatory risk, risks relating to the Company’s ability to execute its business strategy and the benefits realizable therefrom and risks specifically related to the Company’s operations. Additional risk factors can also be found in the Company’s current MD&A and annual information form, both of which have been filed under the Company’s SEDAR profile at www.sedar.com . Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Cision

View original content to download multimedia: http://www.prnewswire.com/news-releases/namaste-technologies-adds-cannmart-labs-as-wholly-owned-subsidiary-and-provides-corporate-update-including-announcement-of-virtual-town-hall-301185602.html

SOURCE Namaste Technologies Inc.

 

Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2020/03/c0630.html Source: https://technical420.com/cannabis-article/namaste-technologies-adds-cannmart-labs-as-wholly-owned-subsidiary-and-provides-corporate-update-including-announcement-of-virtual-town-hall/

Continue Reading

Uncategorized

High Tide Announces Opening of Guelph Retail Cannabis Store

High Tide Inc. (TSXV:HITI) (OTCQB:HITIF) (FRA:2LY), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, is pleased to announce that the Meta Cannabis Co. retail store located at 3 Woodlawn Road West in Guelph, Ontario (the “Guelph Store”) recently received its Retail Store Authorization from the Alcohol and Gaming Commission of […]

The post High Tide Announces Opening of Guelph Retail Cannabis Store appeared first on Technical420.

Republished by Plato

Published

on

High Tide Inc. (TSXV:HITI) (OTCQB:HITIF) (FRA:2LY), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, is pleased to announce that the Meta Cannabis Co. retail store located at 3 Woodlawn Road West in Guelph, Ontario (the “Guelph Store”) recently received its Retail Store Authorization from the Alcohol and Gaming Commission of Ontario (“AGCO”). The Guelph Store will conduct a soft opening on Thursday, December 3, 2020 , with grand opening activities beginning on Friday, December 4 and occurring until Sunday, December 13, 2020 .

Wide dec 2020 w TSXV (CNW Group/High Tide Inc.)

This marks the Company’s 13th branded location in Ontario and 67th retail cannabis store across Canada . “The Guelph Store expands our retail footprint into an exciting new market for High Tide and reinforces our strong position as a leading retailer in Canada’s most populous province,” said Raj Grover, President & Chief Executive Officer of High Tide. “With 11 locations in the AGCO’s queue, and more to come, customers in Ontario can look forward to a steady pipeline of new stores over the next year as we build towards the 30 store provincial maximum by September 2021 .” added Mr. Grover. The city of Guelph is a growing community of over 130,000 people situated in the heart of southern Ontario , and is home to the prominent University of Guelph campus.

About High Tide

High Tide is a retail-focused cannabis company enhanced by the manufacturing and distribution of consumption accessories. The Company is the largest Canadian retailer of recreational cannabis as measured by revenue, with 67 current locations spanning Ontario , Alberta , Manitoba and Saskatchewan . High Tide’s retail segment features the Canna Cabana, KushBar, Meta Cannabis Co., Meta Cannabis Supply Co. and NewLeaf Cannabis banners, with additional locations under development across the country. High Tide has been serving consumers for over a decade through its numerous lifestyle accessory businesses including e-commerce platforms Grasscity.com and CBDcity.com, and its wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. High Tide’s strategy as a parent company is to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value. Key industry investors in High Tide include Aphria Inc. (TSX:APHA) (NYSE:APHA) and Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB).

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements

Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release are based on certain assumptions made by High Tide. While High Tide considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements also necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving the retail cannabis markets; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the retail cannabis industries generally; income tax and regulatory matters; the ability of High Tide to implement its business strategy; competition; currency and interest rate fluctuations; the COVID-19 pandemic nationally and globally and the response of governments to the COVID-19 pandemic in respect of the operation of retail stores and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof, and thus are subject to change thereafter. High Tide disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Factors that could cause anticipated opportunities and actual results to differ materially include, but are not limited to, matters referred to above and elsewhere in High Tide’s public filings and material change reports which are and will be available on SEDAR.

SOURCE High Tide Inc.

 

Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2020/03/c0900.html Source: https://technical420.com/cannabis-article/high-tide-announces-opening-of-guelph-retail-cannabis-store/

Continue Reading

Uncategorized

Fire and Flower Acquires All Of The Outstanding Shares Of Friendly Stranger Holdings

On December 1, pursuant to an arm’s length share purchase agreement (the “Share Purchase Agreement“), Fire & Flower Holdings Corp. (“FAF“) acquired all of the outstanding shares of Friendly Stranger Holdings Corp. (“FSHC“) from FSHC’s shareholders including Green Acre Capital Fund II (Canada) LP, Green Acre Capital Fund II (Listed) LP and Green Acre Capital […]

The post Fire and Flower Acquires All Of The Outstanding Shares Of Friendly Stranger Holdings appeared first on Technical420.

Republished by Plato

Published

on

On December 1, pursuant to an arm’s length share purchase agreement (the “Share Purchase Agreement“), Fire & Flower Holdings Corp. (“FAF“) acquired all of the outstanding shares of Friendly Stranger Holdings Corp. (“FSHC“) from FSHC’s shareholders including Green Acre Capital Fund II (Canada) LP, Green Acre Capital Fund II (Listed) LP and Green Acre Capital Fund II (Non-Resident) LP (collectively, the “Green Acre Entities“) in exchange for common shares of FAF.

Prior to the closing of the transaction contemplated by the Share Purchase Agreement, the Green Acre Entities held convertible debentures of FAF in the principal amount of $8,000,000 (the “Convertible Debentures“) which are convertible into 16,000,000 common shares of FAF at a price of $0.50 per share representing 7% of the outstanding common shares of FAF (including the common shares to be issued upon conversion of the Convertible Debentures). Pursuant to the terms of the Share Purchase Agreement, the Green Acre Entities have acquired control of an aggregate of 14,852,830 common shares of FAF at a deemed value of $0.8034 per share representing 7% of the outstanding shares and, upon conversion of the Convertible Debentures, the Green Acre entities will control an aggregate of 30,852,830 common shares of FAF representing 13.6% of the outstanding common shares of FAF (including the common shares to be issued upon conversion of the Convertible Debentures).

The Green Acre Entities acquired the securities for investment purposes and may, depending on market and other conditions, increase or decrease its beneficial ownership, control or direction over securities of FAF through market transactions, private agreements, treasury issuances, exercise of warrants or otherwise.

The Green Acre Entities’ head office is located at 2 Bloor St. W., Suite 1805, Toronto, Ontario, M4W 3E2. GA is formed under the province of Ontario and its principal business is investments. A copy of the Early Warning Report will appear under the profile of FAF on the SEDAR website at www.sedar.com. FAF’s head office is located at 130 King Street West, Suite 2500, Toronto, Ontario, M5X 1C8.

For further information or to obtain a copy of the Early Warning Report, please contact: Matt Shalhoub, 416-639-9690 or mshalhoub@greenacrecapital.ca.

Cautionary Statements:

Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “intend” and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to the Resulting Issuer’s intended name change. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Resulting Issuer to implement its business strategies; competition; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release is made as of the date hereof and the Resulting Issuer is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.

The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act“), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

NOT FOR DISSEMINATION IN THE U.S. OR THROUGH U.S. NEWSWIRES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/69421

Source: https://technical420.com/cannabis-article/fire-and-flower-acquires-all-of-the-outstanding-shares-of-friendly-stranger-holdings/

Continue Reading
Metal2 days ago

Uğur Dalbeler: Safeguard measures to remain in the spotlight in 2021

Heartland4 days ago

High CBD/low THC content for a new user?

News3 days ago

Bruce Linton-Backed Gage Cannabis Offers Reg A+ Equity Financing

Heartland5 days ago

Anyone try kokonuggz with THC?

Heartland5 days ago

lol

Heartland4 days ago

LASG destroys 1700 illegal shanties, recovers illegal substances at Agege

Heartland4 days ago

CBD oil brain fog

Heartland4 days ago

Celine designer handbags snatched from Melbourne CBD worth $12000

Heartland4 days ago

Cannabis for eye pressure/glaucoma and CBG strains

Heartland4 days ago

Heartland3 days ago

Virginia: Marijuana Legalization Work Group Report Outlines Recommendations

Heartland3 days ago

Heartland4 days ago

How cbd keef is made…

Heartland5 days ago

CBD cartridge for GAD

Heartland5 days ago

lol

Heartland5 days ago

CBD from an Oregon Farm

Heartland5 days ago

Cbd flower and psoriasis?

Heartland5 days ago

Heartland5 days ago

Heartland5 days ago

Heartland4 days ago

Blessed cbd uk

Heartland4 days ago

DIESEL HEMP’S ABACUS DIESEL

Heartland4 days ago

Manufacturing4 days ago

Source for short-run custom box inserts?

Heartland4 days ago

Heartland4 days ago

Heartland4 days ago

Best CBD Deals

Heartland4 days ago

Industrial Hemp Market 2020 Industry Growth Analysis, Industry Growth Analysis, Segmentation …

Heartland3 days ago

King Palm Pre-rolled Cones Surge In Global Popularity

Metal3 days ago

CSN to delay mining IPO to 2021

Trending

A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America